Abuse Potential of Buprenorphine/Naloxone
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 12
- Registration Number
- NCT00149539
- Locations
- πΊπΈ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
- Conditions
- Tobacco Use Disorder
- Interventions
- Drug: Pharmacotherapies for Smoking Cessation
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 293
- Registration Number
- NCT00142831
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Tramadol to Reduce Opioid Withdrawal Symptoms
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 16
- Registration Number
- NCT00142896
- Locations
- πΊπΈ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Opioid Agonist and Antagonist Effects on Opioid Dependence
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 16
- Registration Number
- NCT00142727
- Locations
- πΊπΈ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 30
- Registration Number
- NCT00142870
- Locations
- πΊπΈ
McLean Hospital, Dept. of Psychiatry, Belmont, Massachusetts, United States
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
- Conditions
- Cocaine-Related DisordersOpioid-Related Disorders
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 220
- Registration Number
- NCT00142779
- Locations
- πΊπΈ
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 17
- Registration Number
- NCT00136825
- Locations
- πΊπΈ
Medical University of South Carolina, Charleston, South Carolina, United States
Addition of Naltrexone to Methadone Taper
- Conditions
- Heroin DependenceOpioid-Related DisordersSubstance-Related Disorders
- Interventions
- Drug: Placebo comparator
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 174
- Registration Number
- NCT00135759
- Locations
- πΊπΈ
Duke University, Durham, North Carolina, United States
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
- Conditions
- Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 100
- Registration Number
- NCT00135772
- Locations
- πΊπΈ
UMDNJ - Robert Wood Johnson Medical School, Piscataway, New Jersey, United States
Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 73
- Registration Number
- NCT00135785
- Locations
- πΊπΈ
UCLA Medical Center, Los Angeles, California, United States
πΊπΈRancho Cucamonga Clinic, Rancho Cucamonga, California, United States